RT Journal Article SR Electronic(1) A1 Tannock, Gerald W. A1 Tiong, Ing Soo A1 Priest, Patricia A1 Munro, Karen A1 Taylor, Corinda A1 Richardson, Alice A1 Schultz, MichaelYR 2011 T1 Testing probiotic strain Escherichia coli Nissle 1917 (Mutaflor) for its ability to reduce carriage of multidrug-resistant E. coli by elderly residents in long-term care facilities JF Journal of Medical Microbiology, VO 60 IS 3 SP 366 OP 370 DO https://doi.org/10.1099/jmm.0.025874-0 PB Microbiology Society, SN 1473-5644, AB A high carriage rate of multidrug-resistant Escherichia coli (MDREC) was observed in elderly residents in long-term care facilities. A double-blinded, placebo-controlled trial was carried out to determine whether the probiotic product E. coli strain Nissle 1917 (Mutaflor) would compete with MDREC in the bowel and thereby reduce the prevalence of the multiresistant bacteria in faeces and urine. Sixty-nine patients excreting norfloxacin-resistant E. coli were randomized to probiotic or placebo groups and administered capsules twice daily. The daily dose of probiotic was 5×109–5×1010 bacteria. Faecal and urine samples were cultured at baseline and during and after the treatment period. A reduction in baseline carriage was not influenced by probiotic administration. The probiotic strain was detected in faecal specimens collected during the treatment period of only two out of 12 probiotic group subjects that were tested. Genotyping of norfloxacin-resistant E. coli isolates showed that 32 strains were prevalent among the patients. Thus, E. coli Nissle 1917 does not have the capacity to compete effectively with MDREC in the bowel of elderly patients., UL https://www.microbiologyresearch.org/content/journal/jmm/10.1099/jmm.0.025874-0